ArticlePharmaceuticals (Basel, Switzerland)2021

Clinical Outcomes of Secondary Prophylactic Granulocyte Colony-Stimulating Factors in Breast Cancer Patients at a Risk of Neutropenia with Doxorubicin and Cyclophosphamide-Based Chemotherapy.

Jae Hee Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.